[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342538-105":59,"doc-detail-342538-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cannabigerol-induces-autophagic-cell-death-by-inhibiting-egfr-ras-pathways-in-human-pancreatic-ductal-adenocarcinoma-cell-lines-academic-article-summary","Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines - Academic Article Summary","","Pancreatic ductal adenocarcinoma (PDAC) is an infiltrating and highly lethal pancreatic cancer with poor prognosis driven by limited biomarker availability, aggressive behavior, and treatment resistance. The study evaluates cannabigerol (CBG), a non-psychomimetic cannabinoid with anti-inflammatory activity, for its anticancer effects in human PDAC cell lines PANC-1 and MIAPaCa-2. CBG effects on cell viability, cell death, and EGFR-RAS-associated signaling are assessed using viability assays, apoptosis/death staining with cytofluorimetric analysis, and Western blotting alongside multiplex signaling measurements. The work also tests synergy with gemcitabine and paclitaxel using MTT and SynergyFinder Plus analyses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cannabigerol-induces-autophagic-cell-death-by-inhibiting-egfr-ras-pathways-in-human-pancreatic-ductal-adenocarcinoma-cell-lines-academic-article-summary/342538/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cannabigerol-induces-autophagic-cell-death-by-inhibiting-egfr-ras-pathways-in-human-pancreatic-ductal-adenocarcinoma-cell-lines-academic-article-summary/342538.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is PDAC prognosis poor in the study’s background?","Question",{"text":112,"@type":113},"PDAC has a poor prognosis due to the absence of specific biomarkers, aggressive disease behavior, and resistance to treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What models and readouts are used to test CBG’s anticancer effects?",{"text":117,"@type":113},"The study investigates CBG in PANC-1 and MIAPaCa-2 PDAC cell lines, measuring cell viability and cell death, and assessing EGFR-RAS-associated signaling.",{"name":119,"@type":110,"acceptedAnswer":120},"How is the effect of CBG combined with chemotherapy drugs evaluated?",{"text":121,"@type":113},"Synergy with gemcitabine and paclitaxel is assessed using MTT data together with SynergyFinder Plus software analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342538,1790147629,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Article  \nCannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines  \nLaura Zeppa 1,2,†, Cristina Aguzzi 1,2,†, Maria Beatrice Morelli 1,2, Oliviero Marinelli 1,2, Martina Giangrossi 1, Margherita Luongo 3, Consuelo Amantini 4, Giorgio Santoni 1 and Massimo Nabissi 1,2, *  \nCitation: Zeppa, L.; Aguzzi, C.; Morelli, M.B.; Marinelli, O.; Giangrossi, M.; Luongo, M.; Amantini, C.; Santoni, G.; Nabissi, M. Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Int. J. Mol. Sci. 2024, 25, 2001. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25042001](doi.org/10.3390/ijms25042001)  \nAcademic Editors: Daniela Trono and Beleggia Romina  \nReceived: 16 January 2024  \nRevised: 31 January 2024  \nAccepted: 2 February 2024  \nPublished: 7 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 School of Pharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, MC, Italy;  \n[laura.zeppa@unicam.it](laura.zeppa@unicam.it) (L.Z.); [cristina.aguzzi@unicam.it](cristina.aguzzi@unicam.it) (C.A.); [mariabeatrice.morelli@unicam.it](mariabeatrice.morelli@unicam.it) (M.B.M.); [oliviero.marinelli@unicam.it](oliviero.marinelli@unicam.it) (O.M.); [martina.giangrossi@studenti.unicam.it](martina.giangrossi@studenti.unicam.it) (M.G.);  \n[giorgio.santoni@unicam.it](giorgio.santoni@unicam.it) (G.S.)  \n2 Integrative Therapy Discovery Lab, University of Camerino, 62032 Camerino, MC, Italy  \n3 “Maria Guarino” Foundation—AMOR No Profit Association, 80078 Pozzuoli, NA, Italy  \n4 School of Bioscience and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy; [consuelo.amantini@unicam.it](consuelo.amantini@unicam.it)  \n* [Correspondence: massimo.nabissi@unicam.it](Correspondence: massimo.nabissi@unicam.it); Tel.: +39-0737403306; Fax: +39-0737403325 † These authors contributed equally to this work.  \nAbstract: Pancreatic ductal adenocarcinoma (PDAC) is the most frequent infiltrating type of pancreatic cancer. The poor prognosis associated with this cancer is due to the absence of specific biomarkers, aggressiveness, and treatment resistance. PDAC is a deadly malignancy bearing distinct genetic alterations, the most common being those that result in cancer-causing versions of the KRAS gene. Cannabigerol (CBG) is a non-psychomimetic cannabinoid with anti-inflammatory properties. Regarding the anticancer effect of CBG, up to now, there is only limited evidence in human cancers. To fill this gap, we investigated the effects of CBG on the PDAC cell lines, PANC-1 and MIAPaCa- 2. The effect of CBG activity on cell viability, cell death, and EGFR-RAS-associated signaling was investigated. Moreover, the potential synergistic effect of CBG in combination with gemcitabine (GEM) and paclitaxel (PTX) was investigated. MTT was applied to investigate the effect of CBG on PDAC cell line viabilities. Annexin-V and Acridine orange staining, followed by cytofluorimetric analysis and Western blotting, were used to evaluate CBG’s effect on cell death. The modulation of EGFR-RAS-associated pathways was determined by Western blot analysis and a Milliplex multiplex assay. Moreover, by employing the MTT data and SynergyFinder Plus software analysis, the effect of the combination of CBG and chemotherapeutic drugs was determined.  \nKeywords: cannabigerol; pancreatic cancer; autophagy; chemo-resistance; RAS pathways  \n1. Introduction  \nPancreatic ductal adenocarcinoma (PDAC) is an infiltrating neoplasm derived from the pancreatic ductal tree, and its 5 year overall survival rate increased from 3%","cbCaijmt2SCzQI6J","https://ap.wps.com/l/cbCaijmt2SCzQI6J","pdf",3687194,12,"English","# Abstract\n## Background and rationale\n## Experimental design and cell-line models\n## Assays for viability and cell death\n## Signaling pathway analyses\n## Drug combination and synergy assessment","[{\"question\":\"Why is PDAC prognosis poor in the study’s background?\",\"answer\":\"PDAC has a poor prognosis due to the absence of specific biomarkers, aggressive disease behavior, and resistance to treatment.\"},{\"question\":\"What models and readouts are used to test CBG’s anticancer effects?\",\"answer\":\"The study investigates CBG in PANC-1 and MIAPaCa-2 PDAC cell lines, measuring cell viability and cell death, and assessing EGFR-RAS-associated signaling.\"},{\"question\":\"How is the effect of CBG combined with chemotherapy drugs evaluated?\",\"answer\":\"Synergy with gemcitabine and paclitaxel is assessed using MTT data together with SynergyFinder Plus software analysis.\"}]","Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines - Academic Article Summary | PDF",1790047040,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7cfff95b83f7fea4ec125bca5f8bad12.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c685cb4a2a101f8f2ccb42943270b49.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38e0631a52638b22acd5a16579410e80.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e60adcf7c9f8119a9e83625a43f3c464.webp",980,1385]